Shanghai Taihe Water Technology Development Co.,Ltd. (SHA:605081)
China · Delayed Price · Currency is CNY 12.40
-0.06 (-0.48%)
Aug 1, 2025, 2:45 PM CST
CTI BioPharma Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2020 |
Operating Revenue | 93.87 | 102.55 | 182.92 | 205.41 | 460.29 | 559.93 | Upgrade |
Other Revenue | 0.81 | 0.81 | 0.11 | - | - | - | Upgrade |
| 94.68 | 103.36 | 183.03 | 205.41 | 460.29 | 559.93 | Upgrade | |
Revenue Growth (YoY) | -45.98% | -43.53% | -10.89% | -55.37% | -17.80% | 5.18% | Upgrade |
Cost of Revenue | 118.89 | 118.83 | 200.19 | 113.33 | 173.7 | 230.32 | Upgrade |
Gross Profit | -24.21 | -15.47 | -17.16 | 92.08 | 286.59 | 329.61 | Upgrade |
Selling, General & Admin | 101.35 | 102.6 | 126.55 | 97.01 | 94.13 | 90.68 | Upgrade |
Research & Development | 6.46 | 7.38 | 18.67 | 22.79 | 24.96 | 22.78 | Upgrade |
Other Operating Expenses | 6.08 | 2.95 | 2.72 | 3 | 2.56 | 7.13 | Upgrade |
Operating Expenses | 282.47 | 277.93 | 219.1 | 288.16 | 201.82 | 150.61 | Upgrade |
Operating Income | -306.67 | -293.4 | -236.26 | -196.08 | 84.77 | 179 | Upgrade |
Interest Expense | -0.2 | -0.2 | -0.13 | - | - | - | Upgrade |
Interest & Investment Income | 4.02 | 5.3 | 9.1 | 12.19 | 14.26 | 1.95 | Upgrade |
Earnings From Equity Investments | - | - | - | - | -0.03 | -0.35 | Upgrade |
Other Non Operating Income (Expenses) | -2.6 | -3.86 | -0.56 | -3.29 | 0.09 | 2.02 | Upgrade |
EBT Excluding Unusual Items | -305.45 | -292.16 | -227.85 | -187.18 | 99.09 | 182.61 | Upgrade |
Impairment of Goodwill | -29.33 | -29.33 | -2.47 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | 8.4 | 8.4 | - | -0.03 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | 0.47 | 0.47 | -0.11 | -0 | 0.01 | -0.12 | Upgrade |
Asset Writedown | -16.82 | -18.78 | - | -0.08 | -0.24 | -0 | Upgrade |
Legal Settlements | -0.56 | -0.56 | -0.13 | - | - | - | Upgrade |
Other Unusual Items | -3.36 | -3.4 | -3.95 | 1.34 | 1.83 | 5.63 | Upgrade |
Pretax Income | -346.66 | -335.37 | -234.51 | -185.95 | 100.69 | 188.12 | Upgrade |
Income Tax Expense | -0.39 | -0.55 | 53.16 | -25.64 | 9.75 | 26.52 | Upgrade |
Earnings From Continuing Operations | -346.27 | -334.82 | -287.66 | -160.31 | 90.94 | 161.6 | Upgrade |
Minority Interest in Earnings | 0.67 | 0.33 | 0.22 | 0 | 0 | - | Upgrade |
Net Income | -345.6 | -334.49 | -287.44 | -160.31 | 90.94 | 161.6 | Upgrade |
Net Income to Common | -345.6 | -334.49 | -287.44 | -160.31 | 90.94 | 161.6 | Upgrade |
Net Income Growth | - | - | - | - | -43.72% | 9.26% | Upgrade |
Shares Outstanding (Basic) | 116 | 113 | 113 | 113 | 110 | 85 | Upgrade |
Shares Outstanding (Diluted) | 116 | 113 | 113 | 113 | 110 | 85 | Upgrade |
Shares Change (YoY) | -0.41% | 0.20% | 0.24% | 3.03% | 29.06% | 0.16% | Upgrade |
EPS (Basic) | -2.98 | -2.95 | -2.54 | -1.42 | 0.83 | 1.90 | Upgrade |
EPS (Diluted) | -2.98 | -2.95 | -2.54 | -1.42 | 0.83 | 1.90 | Upgrade |
EPS Growth | - | - | - | - | -56.39% | 9.09% | Upgrade |
Free Cash Flow | -172.71 | -172.42 | -122.03 | -160.33 | -196.68 | 5.95 | Upgrade |
Free Cash Flow Per Share | -1.49 | -1.52 | -1.08 | -1.42 | -1.79 | 0.07 | Upgrade |
Dividend Per Share | - | - | - | - | 0.690 | - | Upgrade |
Gross Margin | -25.57% | -14.96% | -9.38% | 44.83% | 62.26% | 58.87% | Upgrade |
Operating Margin | -323.91% | -283.87% | -129.09% | -95.46% | 18.42% | 31.97% | Upgrade |
Profit Margin | -365.02% | -323.62% | -157.04% | -78.04% | 19.76% | 28.86% | Upgrade |
Free Cash Flow Margin | -182.41% | -166.82% | -66.67% | -78.05% | -42.73% | 1.06% | Upgrade |
EBITDA | -285.6 | -272.69 | -216.97 | -178.64 | 90.09 | 182.75 | Upgrade |
EBITDA Margin | - | -263.83% | -118.54% | -86.97% | 19.57% | 32.64% | Upgrade |
D&A For EBITDA | 21.07 | 20.72 | 19.29 | 17.43 | 5.32 | 3.75 | Upgrade |
EBIT | -306.67 | -293.4 | -236.26 | -196.08 | 84.77 | 179 | Upgrade |
EBIT Margin | - | -283.87% | -129.09% | -95.46% | 18.42% | 31.97% | Upgrade |
Effective Tax Rate | - | - | - | - | 9.68% | 14.10% | Upgrade |
Revenue as Reported | 94.68 | 103.36 | 183.03 | 205.41 | 460.29 | 559.93 | Upgrade |
Advertising Expenses | - | 2.69 | 5.58 | 1.01 | 1.27 | 0.44 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.